Clinical Trial Site Activation: 6 Steps From Selection to Initiation

A Tufts CSDD survey of more than 300 people at sponsors and CROs found that getting from site identification to site initiation took about 31 weeks on average, and that 11% of sites were never activated (Clinical Leader). Site activation is the stretch of study start-up between choosing a site and that site being ready to enrol.

The steps are broadly the same for every study, though their order overlaps and local rules vary. Here are the six, what each involves, and where time is usually lost.

The six steps at a glance

1. Identification and feasibility

The study team identifies possible sites, often starting from sites it has worked with before, and sends feasibility questionnaires about patients, staff, equipment and competing studies.

2. Selection and confidentiality

Sites are selected from the feasibility responses, and confidentiality agreements are signed so the full protocol can be shared.

3. Qualification visit

A pre-study or site qualification visit, in person or remote, confirms that the site has the investigator, staff, facilities and patient population the study needs.

4. Contract and budget

The clinical trial agreement and site budget are negotiated. Contract negotiations have been reported to average more than 100 days, making this one of the longest steps (ACRP).

5. Approvals and essential documents

Ethics and regulatory approvals are obtained, and essential documents, such as investigator CVs, licences, delegation logs and lab certifications, are collected. In the EU, the Clinical Trials Regulation sets the authorisation timeline; in the UK, combined review covers ethics and regulatory review in one application since April 2026.

6. Initiation and activation

The site initiation visit trains the site team on the protocol and systems. The site is activated once approvals, contracts, documents, system access and investigational product are all in place, and can then start enrolling.

Site activation checklist

• Start feasibility from sites with past performance data
• Send confidentiality agreements with the feasibility survey
• Run contract, budget and approvals in parallel, not one after another
• Use a standard list of essential documents per country
• Track each site's status through all six steps in one place
• Confirm system access and drug supply before the initiation visit

What this means by role

• New start-up and clinical operations staff: these six steps are the backbone of every study start-up.
• CTMs and CTAs: running steps 4 and 5 in parallel is the biggest time saver.
• CRAs: the qualification and initiation visits are where you see the site first-hand.
• CRCs and site staff: having essential documents ready speeds up step 5 for every study.

How Cloudbyz helps

Cloudbyz CTMS and Study Start-Up, built natively on Salesforce, track every site through feasibility, selection, qualification, contracts, approvals and initiation, with budgets in Cloudbyz CTFM and documents in Cloudbyz eTMF on the same platform. See how Cloudbyz handles study start-up or visit cloudbyz.com.